Explore the latest news about Venture Partners at CU Ƶ and keep up to date on the impact CU's startups and technologies are making.

Vegan hamburger

Meati Foods announces its inaugural “Meati Culinary Collective” led by world-renowned celebrity chefs

Feb. 27, 2023

VegWorld Magazine—Meati Foods, a CU Ƶ spinout and the producer of delicious animal-free, whole-food protein, this week debuted an evolving chef partnership series coined the “Meati Culinary Collective,” featuring Meati’s mushroom root-based creations as prepared by a diverse roster of celebrated chefs.

Stan Hickory

New Venture Challenge’s Hickory steps into Innovation & Entrepreneurship director role

Feb. 22, 2023

The Research & Innovation Office has announced several leadership transitions within the campuswide Innovation & Entrepreneurship Initiative, with Stan Hickory stepping into the role of director of the initiative, a position held by Chris Gustavson since 2019.

Illustration of DNA

To Health: Xalud Therapeutics is bringing gene therapy to the masses

Feb. 8, 2023

GEN—Xalud Therapeutics, a CU Ƶ spinout, is developing a non-viral DNA-delivered therapy platform to treat conditions caused by pathologic inflammation

Microscopic picture of bacteria

We’re not so different: Bacterial weapons could help fight human diseases

Feb. 8, 2023

New research from CU Ƶ could ultimately pave the way to novel approaches for treating a host of human diseases, from autoimmune disorders like Rheumatoid arthritis and Crohn’s disease to neurodegenerative diseases like Parkinson’s disease.

Diagram

CU Ƶ flow imaging software highlighted by FDA

Feb. 8, 2023

FDA—Flow imaging software from Theodore W. Randolph's (College of Engineering and Applied Sciences) lab and licensed to SentrySciences to create their ParticleSentryAI product was recently highlighted by the FDA in advancing drug product quality.

Mushroom cutlet

Mushroom protein company Meati Foods opens ‘mega’ facility; closes $22M in new funding

Jan. 26, 2023

TechCrunch—Meati Foods, a CU Ƶ spinout, is closer to full-scale production of its whole-food protein made from the structural fibers of mushrooms, known as mycelium. The company announced Thursday the opening of its production facility, dubbed “Mega Ranch,” in Colorado.

Employee group photo

Inscripta is reimagining what the synthetic biology company of the future will be

Jan. 25, 2023

Forbes—CU Ƶ startup Inscripta, a global leader in genome engineering, is reshaping the image of a synthetic biology company. Biomanufacturing is set to transform many industries by making the products that the world needs cleaner, more efficient and more sustainable.

LongPath Technologies

LongPath welcomes Sam Cummings as chief financial officer and Joe Quoyeser as chief commercial officer

Jan. 23, 2023

LongPath Technologies Inc.—LongPath, a CU Ƶ startup and monitoring service providing continuous detection and quantification of methane emissions for the oil field, announced the appointment of Sam Cummings as executive vice president for strategy and chief financial officer and Joe Quoyeser as senior vice president and chief commercial officer.

Science lab equipment

Inscripta® acquires Infinome Biosciences and Sestina Bio to advance sustainable biomanufacturing

Jan. 18, 2023

<p>CU Ƶ spinout Inscripta®, a global leader in genome engineering technology, announced the acquisition of two pioneers of synthetic biology—Infinome Biosciences and Sestina Bio, which advance Inscripta’s strategy to develop and commercialize bio-manufactured products for a broad spectrum of industrial and consumer markets. </p>

Pipette dripping orange liquid

InDevR Raises $9M in Series B financing and partners with bioMérieux

Jan. 17, 2023

CU Ƶ spinout InDevR Inc, a provider of analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux $5 million. Together, these investments will support InDevR’s commercial expansion and ongoing development of new reagent kits for its VaxArray® platform.

Pages